birabresib
Showing 1 - 3 of 3
NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)
Terminated
- NUT Midline Carcinoma (NMC)
- +3 more
- Birabresib
- (no location specified)
Jan 7, 2021